Subscribe To
Electric train orders grow: how caterpillar could be a winner
Investors and consumers have likely heard of electric cars, electric trucks and electric semis by now. One vehicle that hasn't gotten as much attentio...
February 4, 2022, 3:03 pm
Electric train orders grow: how caterpillar could be a winner
Investors and consumers have likely heard of electric cars, electric trucks and electric semis by now. One vehicle that hasn't gotten as much attentio...
February 4, 2022, 3:03 pm
Aptiv's latest investment shows that software-defined vehicles are here to stay
Automakers keen to sell vehicles loaded with features and software services — in a bid to generate more revenue — have an information overload cha...
February 3, 2022, 5:30 pm
Aptiv's latest investment shows that software-defined vehicles are here to stay
Automakers keen to sell vehicles loaded with features and software services — in a bid to generate more revenue — have an information overload cha...
February 3, 2022, 5:30 pm
Aptiv's latest investment shows that software-defined vehicles are here to stay
Automakers keen to sell vehicles loaded with features and software services — in a bid to generate more revenue — have an information overload cha...
February 3, 2022, 5:30 pm
Afc energy's extreme e contract renewed for second season
AFC Energy had its contract to power the Extreme E all-electric SUV racing extended to cover the 2022 season of races. The fuel cell developer's "...
February 2, 2022, 2:35 am
Afc energy's extreme e contract renewed for second season
AFC Energy had its contract to power the Extreme E all-electric SUV racing extended to cover the 2022 season of races. The fuel cell developer's "...
February 2, 2022, 2:35 am
Afc energy's extreme e contract renewed for second season
AFC Energy had its contract to power the Extreme E all-electric SUV racing extended to cover the 2022 season of races. The fuel cell developer's "...
February 2, 2022, 2:35 am
Value seekers ought to have moderna on their radar now
Even as MRNA stock plumbs new depths, Moderna's commitment to combat Covid-19 variant strains offers ho...
January 31, 2022, 4:44 pm
Value seekers ought to have moderna on their radar now
Even as MRNA stock plumbs new depths, Moderna's commitment to combat Covid-19 variant strains offers ho...
January 31, 2022, 4:44 pm
Value seekers ought to have moderna on their radar now
Even as MRNA stock plumbs new depths, Moderna's commitment to combat Covid-19 variant strains offers ho...
January 31, 2022, 4:44 pm
Cef weekly market review: when it rains it pours
CEF Weekly Market Review: When It rains It Pours...
January 29, 2022, 7:52 am
Cef weekly market review: when it rains it pours
CEF Weekly Market Review: When It rains It Pours...
January 29, 2022, 7:52 am
Cef weekly market review: when it rains it pours
CEF Weekly Market Review: When It rains It Pours...
January 29, 2022, 7:52 am
Gavilon deal to make glencore major soy exporter in brazil with larger u.s. foothold
Global commodities merchant Glencore Plc took a major step this week to becoming a greater force in the international food chain with a deal to buy th...
January 27, 2022, 3:20 pm
Gavilon deal to make glencore major soy exporter in brazil with larger u.s. foothold
Global commodities merchant Glencore Plc took a major step this week to becoming a greater force in the international food chain with a deal to buy th...
January 27, 2022, 3:20 pm
Gavilon deal to make glencore major soy exporter in brazil with larger u.s. foothold
Global commodities merchant Glencore Plc took a major step this week to becoming a greater force in the international food chain with a deal to buy th...
January 27, 2022, 3:20 pm
Brainstorm cell therapeutics to present at the 12th annual california als research summit
NEW YORK, Jan. 27, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neur...
January 27, 2022, 7:00 am
Brainstorm cell therapeutics to present at the 12th annual california als research summit
NEW YORK, Jan. 27, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neur...
January 27, 2022, 7:00 am
Brainstorm cell therapeutics to present at the 12th annual california als research summit
NEW YORK, Jan. 27, 2022 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neur...
January 27, 2022, 7:00 am